Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Advances in Virus Research
|
October 25, 2024
Human norovirus cultivation models, immune response and vaccine landscape
Thomas D Burton, Julio Carrera Montoya, Thalia Frota, et al.
Virology
|
December 20, 2023
Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro
Caolingzhi Tang, Julio Carrera Montoya, Svenja Fritzlar, et al.
Materials Horizons
|
February 24, 2026
3D printed photo-sensitized microfiltration membranes for simultaneous water filtration and pathogen management
Hooralain Bushnaq, Hari Kalathil Balakrishnan, Tom Burton, et al.
Water Research
|
February 26, 2025
Visible light photosensitised cross-flow microfiltration membrane reactors for managing microplastic-contaminated bio-effluents
Hooralain Bushnaq, Sisi Pu, Tom Burton, et al.
Foods (Basel, Switzerland)
|
November 9, 2024
Antimicrobial Efficacy of GS-2 on Reusable Food Packaging Materials for Specialty Crops
Catherine W Y Wong, Thomas Burton, Julio Carrera Montoya, et al.
Plos Pathogens
|
September 3, 2024
Norovirus-mediated translation repression promotes macrophage cell death
Turgut E Aktepe, Joshua M Deerain, Jennifer L Hyde, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 14, 2025
Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia
Simon Collett, Linda Earnest, Melissa A Edeling, et al.
Biotechnology and Bioengineering
|
February 12, 2025
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
Melissa A Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Frontiers in Microbiology
|
June 23, 2023
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
Simon Collett, Linda Earnest, Julio Carrera Montoya, et al.
NPJ Vaccines
|
January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Advances in Virus Research
|
October 25, 2024
Human norovirus cultivation models, immune response and vaccine landscape
Thomas D Burton, Julio Carrera Montoya, Thalia Frota, et al.
Virology
|
December 20, 2023
Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro
Caolingzhi Tang, Julio Carrera Montoya, Svenja Fritzlar, et al.
Materials Horizons
|
February 24, 2026
3D printed photo-sensitized microfiltration membranes for simultaneous water filtration and pathogen management
Hooralain Bushnaq, Hari Kalathil Balakrishnan, Tom Burton, et al.
Water Research
|
February 26, 2025
Visible light photosensitised cross-flow microfiltration membrane reactors for managing microplastic-contaminated bio-effluents
Hooralain Bushnaq, Sisi Pu, Tom Burton, et al.
Foods (Basel, Switzerland)
|
November 9, 2024
Antimicrobial Efficacy of GS-2 on Reusable Food Packaging Materials for Specialty Crops
Catherine W Y Wong, Thomas Burton, Julio Carrera Montoya, et al.
Plos Pathogens
|
September 3, 2024
Norovirus-mediated translation repression promotes macrophage cell death
Turgut E Aktepe, Joshua M Deerain, Jennifer L Hyde, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 14, 2025
Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia
Simon Collett, Linda Earnest, Melissa A Edeling, et al.
Biotechnology and Bioengineering
|
February 12, 2025
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
Melissa A Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Frontiers in Microbiology
|
June 23, 2023
Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
Simon Collett, Linda Earnest, Julio Carrera Montoya, et al.
NPJ Vaccines
|
January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Page
of 2